Greenwich LifeSciences: Persevering CEO And Interesting Data
Maskot/DigitalVision via Getty Images Greenwich LifeSciences, Inc. (NASDAQ:GLSI) is a developer of cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. A 2-year IPO with a 2 decades history, GLSI had been lagging over an […]
